Durvalumab vs Levodopa

## Durvalumab vs Levodopa: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Levodopa**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Levodopa — 1.5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Levodopa — C9H11NO4.

**Molecular Weight**: Durvalumab — N/A; Levodopa — 197.1880 g/mol.

**Type**: Durvalumab — Antibody; Levodopa — Small molecule.